Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Mizuho analyst Joseph Catanzaro downgraded Apogee Therapeutics Inc (NASDAQ:APGE) from Outperform to Neutral and raised the price target from $110 to $135. Apogee Therapeutics shares closed at $132.88 on Tuesday. See how other analysts view this stock.
• Raymond James analyst Brian Gesuale downgraded V2X Inc (NYSE:VVX) from Outperform to Market Perform. V2X shares closed at $83.29 on Tuesday. See how other analysts view this stock.
• B of A Securities analyst Joshua Shanker downgraded Principal Financial Group Inc (NASDAQ:PFG) from Neutral to Underperform and slashed the price target from $98 to $95. Principal Financial shares closed at $132.88 on Tuesday. See how other analysts view this stock.
• Daiwa Capital analyst John Choi downgraded JD.Com Inc (NASDAQ:JD) from Buy to Hold. JD.com shares closed at $26.12 on Tuesday. See how other analysts view this stock.
• Bernstein analyst Jeffrey Walch downgraded Nuvalent, Inc (NASDAQ:NUVL) from Outperform to Market Perform and cut the price target from $172 to $124. Nuvalent shares closed at $123.44 on Tuesday. See how other analysts view this stock.

Considering buying PFG stock? Here’s what analysts think:

Photo via Shutterstock